Literature DB >> 8063654

Relationship between fat-free mass and urinary excretion of creatinine and 3-methylhistidine in adult humans.

F Virgili1, G Maiani, Z H Zahoor, D Ciarapica, A Raguzzini, A Ferro-Luzzi.   

Abstract

The urinary excretion of endogenous creatinine (CRTN) and 3-methylhistidine (3-MH) has been proposed as a predictor of fat-free mass (FFM) in healthy subjects. In this study, we report the relationship between FFM, estimated by densitometry plus deuterium dilution, and daily urinary excretion of CRTN and 3-MH in a sample of 20 healthy adult subjects of both sexes. 3-MH and CRTN were measured in 2 days of urine collection, which followed 4 days of meat-free diet. Meat-free diet was maintained throughout the period of urine collection. The mean of 2 days of excretion of 3-MH was 237.7 +/- 87.3 (SD) and 138.9 +/- 31.2 mumol/day in men and women, respectively. The mean CRTN excretion was 1.51 +/- 0.22 and 0.98 +/- 0.15 g/day in men and women, respectively. CRTN excretion was found well associated with FFM (R2 = 0.89; P < 0.0001), whereas 3-MH was lightly associated with FFM (R2 = 0.33; P < 0.01). Residuals from the regression of 3-MH vs. FFM were found to be correlated with CRTN excretion and FFM (R2 = 0.57 and 0.67, respectively), suggesting that muscularity and the absolute amount of lean mass are relevant for the error in predicting FFM from 3-MH excretion. Data confirm that urinary CRTN excretion can be an expedient indirect method for evaluating body composition in healthy adult subjects. Data also suggest that the relationship between 3-MH and FFM is complex, limiting the possibility of predicting body composition from the excretion of this metabolite.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8063654     DOI: 10.1152/jappl.1994.76.5.1946

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  4 in total

1.  Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.

Authors:  Meredith C Foster; Josef Coresh; Joseph V Bonventre; Venkata S Sabbisetti; Sushrut S Waikar; Theodore E Mifflin; Robert G Nelson; Morgan Grams; Harold I Feldman; Ramachandran S Vasan; Paul L Kimmel; Chi-Yuan Hsu; Kathleen D Liu
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-08       Impact factor: 8.237

2.  Creatinine normalization in biological monitoring revisited: the case of 1-hydroxypyrene.

Authors:  C Viau; M Lafontaine; J P Payan
Journal:  Int Arch Occup Environ Health       Date:  2004-02-04       Impact factor: 3.015

3.  Metabolomic response to collegiate football participation: Pre- and Post-season analysis.

Authors:  Nicole L Vike; Sumra Bari; Khrystyna Stetsiv; Thomas M Talavage; Eric A Nauman; Linda Papa; Semyon Slobounov; Hans C Breiter; Marilyn C Cornelis
Journal:  Sci Rep       Date:  2022-02-23       Impact factor: 4.379

Review 4.  Nutritional and Nutrition-Related Biomarkers as Prognostic Factors of Sarcopenia, and Their Role in Disease Progression.

Authors:  Sousana K Papadopoulou; Gavriela Voulgaridou; Foivi S Kondyli; Mariella Drakaki; Kyriaki Sianidou; Rozalia Andrianopoulou; Nikolaos Rodopaios; Agathi Pritsa
Journal:  Diseases       Date:  2022-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.